A small Swiss biotech has terminated a mid-stage test of a new type of oral drug for people with Alzheimer's disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback